To Evaluate the Safety, Efficacy and Kinetic Characteristics of TRD205 Tablets for Postoperative Analgesia After Unilateral Hallux Valgus Orthopedic Surgery

Phase 1 Not yet recruiting 32 enrolled Beijing Tide Pharmaceutical Co., Ltd Beijing Jishuitan Hospital · collab

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a multicenter, randomized, double-blind, placebo-controlled phase Ib study designed to evaluate the safety, efficacy and PK of TRD205 tablets administered orally .

Timeline

Start: 2025-08-26
Primary completion: 2025-12-27
Completion: 2025-12-27

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	TRD205	Unknown	200 mg	Oral
Subject	TRD205	Unknown	400 mg	Oral
Subject	TRD205	Unknown	600 mg	Oral

Indications

No indication recorded.